Chinese Drug Makers Progress HER2 ADCs Amid Enhertu Dominance

 
• By Dexter Jie Yan
  
chase
Seven Chinese fast-followers of Enhertu are chasing the blockbuster drug in the domestic market. (Shutterstock)

More from Clinical Trials

More from R&D